NCT00003476View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Childhood Brain Tumor
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Children with a primary malignant brain tumor will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER